Epithalon - Beligas Pharmaceuticals

In laboratory settings, Epithalon has been administered in different forms, including oral, subcutaneous, and intramuscular injections. Animal studies typically used subcutaneous dosing, with estimated human equivalents around 0.8 mcg/kg daily for injections and 30 mcg/kg orally. However, guidance for human administration is sparse as it is still experimental. Available as a gray-market supplement, Epithalon is commonly supplied as injectable powders to be mixed with bacteriostatic water, but no standardized dosing recommendations exist due to its unapproved status​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Epithalon by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.